Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Patients will receive standard of care radiation therapy to the primary tumor of the head and neck and involved nodal metastasis and draining nodal basin and either weekly cisplatin or every 3-week cisplatin in locally advanced SCCHN. The relationship between cisplatin toxicity and the level of reactive oxygen species generated by the drug in subjects with squamous cell carcinoma of the head and neck treated on this trial.
Epistemonikos ID: c3e0452c64998f1de50c4f17c035151e08c5f937
First added on: May 20, 2024